Challenges in the diagnosis and management of neonatal sepsis

Journal of Tropical Pediatrics

Volumn 61, Issue 1, 2015, Pages 1-13

  Zea Vera, Alonso ^a   Ochoa, Theresa J ^a,b  

^a INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CEFOTAXIME; COTRIMOXAZOLE; DEXAMETHASONE; INTERLEUKIN 6; PENICILLIN DERIVATIVE; PROCALCITONIN; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CELL COUNT; BLOOD CULTURE; CHEMOPROPHYLAXIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; DIAGNOSTIC TEST ACCURACY STUDY; ESCHERICHIA COLI; HIGH RISK INFANT; HUMAN; IMMUNE RESPONSE; LISTERIA MONOCYTOGENES; LUMBAR PUNCTURE; MOLECULAR DIAGNOSIS; NEWBORN; NEWBORN CARE; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; NEWBORN PERIOD; NEWBORN SEPSIS; NONHUMAN; PARENTERAL NUTRITION; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREDICTIVE VALUE; PREMATURITY; PROTEIN BLOOD LEVEL; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; TREATMENT FAILURE; BACTERIAL INFECTIONS; INCIDENCE; INFANT; INFANT MORTALITY; INFANT, NEWBORN, DISEASES; INFANT, PREMATURE, DISEASES; MICROBIOLOGY; SEPSIS;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; HUMANS; INCIDENCE; INFANT; INFANT MORTALITY; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; SEPSIS;

EID: 84929400996     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmu079     Document Type: Article

References (94)

1. Wang H, Liddell CA, Coates MM, et al. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384:957-79.
2. Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012; 379:2151-61.
3. Lawn JE, Cousens S, Zupan J, et al. 4 million neonatal deaths: when? Where? Why? Lancet 2005;365:891-900.
4. Thaver D, Zaidi AKM. Burden of neonatal infections in developing countries: a review of evidence from communitybased studies. Pediatr Infect Dis J 2009;28(1 Suppl):S3-9.
5. Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin North Am 2013;60:367-89.
6. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007;7: 379-90.
7. Malek A, Sager R, Kuhn P, et al. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol 1996;36:248-55.
8. Stephens BE, Vohr BR. Neurodevelopmental outcome of the premature infant. Pediatr Clin North Am 2009;56: 631-46.
9. Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004;292:2357-65.
10. Oeser C, Lutsar I, Metsvaht T, et al. Clinical trials in neonatal sepsis. J Antimicrob Chemother 2013;68:2733-45.
11. Ganatra HA, Zaidi AKM. Neonatal infections in the developing world. Semin Perinatol 2010;34:416-25.
12. Shane AL, Stoll BJ. Neonatal sepsis: progress towards improved outcomes. J Infect 2014;68:S24-32.
13. Puopolo KM, Draper D, Wi S, et al. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors. Pediatrics 2011;128:e1155-63.
14. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110:285-91.
15. Vergnano S, Menson E, Kennea N, et al. Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed 2011;96:F9-14.
16. Stoll BJ, Hansen NI, Sánchez PJ, et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 2011;127: 817-26.
17. Muller-Pebody B, Johnson AP, Heath PT, et al. Empirical treatment of neonatal sepsis: are the current guidelines adequate? Arch Dis Child Fetal Neonatal Ed 2011;96: F4-8.
18. Zaidi AKM, Huskins WC, Thaver D, et al. Hospitalacquired neonatal infections in developing countries. Lancet 2005;365:1175-88.
19. Zaidi AKM, Thaver D, Ali SA, et al. Pathogens associated with sepsis in newborns and young infants in developing countries. Pediatr Infect Dis J 2009;28(1 Suppl):S10-8.
20. Downie L, Armiento R, Subhi R, et al. Communityacquired neonatal and infant sepsis in developing countries: efficacy of WHO's currently recommended antibiotics-systematic review and meta-analysis. Arch Dis Child 2013;98:146-54.
21. Young Infants Clinical Signs Study Group. Clinical signs that predict severe illness in children under age 2 months: a multicentre study. Lancet 2008;371:135-42.
22. Opiyo N, English M. What clinical signs best identify severe illness in young infants aged 0-59 days in developing countries? A systematic review. Arch Dis Child 2011;96: 1052-9.
23. Baqui AH, El-Arifeen S, Darmstadt GL, et al. Effect of community-based newborn-care intervention package implemented through two service-delivery strategies in Sylhet district, Bangladesh: a cluster-randomised controlled trial. Lancet 2008;371:1936-44.
24. Bang AT, Bang RA, Baitule SB, et al. Effect of homebased neonatal care and management of sepsis on neonatal mortality: field trial in rural India. Lancet 1999;354:1955-61.
25. Neal PR, Kleiman MB, Reynolds JK, et al. Volume of blood submitted for culture from neonates. J Clin Microbiol 1986;24:353-6.
26. Dietzman DE, Fischer GW, Schoenknecht FD. Neonatal Escherichia coli septicemia-bacterial counts in blood. J Pediatr 1974;85:128-30.
27. Kellogg JA, Ferrentino FL, Goodstein MH, et al. Frequency of low level bacteremia in infants from birth to two months of age. Pediatr Infect Dis J 1997;16:381-5.
28. Schelonka RL, Chai MK, Yoder BA, et al. Volume of blood required to detect common neonatal pathogens. J Pediatr 1996;129:275-8.
29. Wiswell TE, Hachey WE. Multiple site blood cultures in the initial evaluation for neonatal sepsis during the first week of life. Pediatr Infect Dis J 1991;10:365-9.
30. Sarkar S, Bhagat I, DeCristofaro JD, et al. A study of the role of multiple site blood cultures in the evaluation of neonatal sepsis. J Perinatol 2005;26:18-22.
31. Yager P, Edwards T, Fu E, et al. Microfluidic diagnostic technologies for global public health. Nature 2006;442: 412-8.
32. Pammi M, Flores A, Leeflang M, et al. Molecular assays in the diagnosis of neonatal sepsis: a systematic review and meta-analysis. Pediatrics 2011;128:e973-85.
33. Liu CL, Ai HW, Wang WP, et al. Comparison of 16S rRNA gene PCR and blood culture for diagnosis of neonatal sepsis. Arch Pediatr 2014;21:162-9.
34. Hornik CP, Benjamin DK, Becker KC, et al. Use of the complete blood cell count in early-onset neonatal sepsis. Pediatr Infect Dis J 2012;31:799-802.
35. Hornik CP, Benjamin DK, Becker KC, et al. Use of the complete blood cell count in late-onset neonatal sepsis. Pediatr Infect Dis J 2012;31:803-7.
36. Benitz WE, Han MY, Madan A, et al. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics 1998;102:E41.
37. Pourcyrous M, Bada HS, Korones SB, et al. Significance of serial C-reactive protein responses in neonatal infection and other disorders. Pediatrics 1993;92:431-5.
38. Meem M, Modak JK, Mortuza R, et al. Biomarkers for diagnosis of neonatal infections: A systematic analysis of their potential as a point-of-care diagnostics. J Glob Health 2011;1:201-9.
39. Chiesa C, Natale F, Pascone R, et al. C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period. Clin Chim Acta 2011;412:1053-9.
40. Hofer N, Müller W, Resch B. Non-infectious conditions and gestational age influence C-reactive protein values in newborns during the first 3 days of life. Clin Chem Lab Med 2011;49:297-302.
41. Vouloumanou EK, Plessa E, Karageorgopoulos DE, et al. Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. Intensive Care Med 2011;37:747-62.
42. Du J, Li L, Dou Y, et al. Diagnostic utility of neutrophil CD64 as a marker for early-onset sepsis in preterm neonates. PloS One 2014;9:e102647.
43. Haque KN. Definitions of bloodstream infection in the newborn. Pediatr Crit Care Med 2005;6(3 Suppl): S45-9.
44. Zea-Vera A, Turin CG, Ochoa TJ. Unifying criteria for late neonatal sepsis: proposal for an algorithm of diagnostic surveillance [in Spanish]. Rev Peru Med Exp Salud Pública 2014;31:358-63.
45. Marchant EA, Boyce GK, Sadarangani M, et al. Neonatal sepsis due to coagulase-negative staphylococci. Clin Dev Immunol 2013;2013:586076.
46. Healy CM, Baker CJ, Palazzi DL, et al. Distinguishing true coagulase-negative Staphylococcus infections from contaminants in the neonatal intensive care unit. J Perinatol 2013;33:52-8.
47. Patrick SW, Schumacher RE, Davis MM. Variation in lumbar punctures for early onset neonatal sepsis: a nationally representative serial cross-sectional analysis, 2003-2009. BMC Pediatr 2012;12:134.
48. MacMahon P, Jewes L, de Louvois J. Routine lumbar punctures in the newborn-are they justified? Eur J Pediatr 1990;149:797-9.
49. Stoll BJ, Hansen N, Fanaroff AA, et al. To tap or not to tap: high likelihood of meningitis without sepsis among very low birth weight infants. Pediatrics 2004;113:1181-6.
50. Cohen-Wolkowiez M, Smith PB, Mangum B, et al. Neonatal Candida meningitis: significance of cerebrospinal fluid parameters and blood cultures. J Perinatol 2007;27:97-100.
51. Fielkow S, Reuter S, Gotoff SP. Cerebrospinal fluid examination in symptom-free infants with risk factors for infection. J Pediatr 1991;119:971-3.
52. Rubin LG, Sánchez PJ, Siegel J, et al. Evaluation and treatment of neonates with suspected late-onset sepsis: a survey of neonatologists' practices. Pediatrics 2002;110:e42.
53. Sivanandan S, Soraisham AS, Swarnam K. Choice and duration of antimicrobial therapy for neonatal sepsis and meningitis. Int J Pediatr 2011;2011:712150.
54. Clark RH, Bloom BT, Spitzer AR, et al. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics 2006;117:1979-87.
55. Cantey JB, Wozniak PS, Sánchez PJ. Prospective surveillance of antibiotic use in the neonatal intensive care unit: results from the SCOUT study. Pediatr Infect Dis J 2014 (Epub ahead of print).
56. Patel SJ, Oshodi A, Prasad P, et al. Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12 Step Campaign to Prevent Antimicrobial Resistance. Pediatr Infect Dis J 2009;28:1047-51.
57. Tzialla C, Borghesi A, Perotti GF, et al. Use and misuse of antibiotics in the neonatal intensive care unit. J Matern Fetal Neonatal Med 2012;25(Suppl 4):35-7.
58. De Man P, Verhoeven BA, Verbrugh HA, et al. An antibiotic policy to prevent emergence of resistant bacilli. Lancet 2000;355:973-8.
59. Le J, Nguyen T, Okamoto M, et al. Impact of empiric antibiotic use on development of infections caused by extended-spectrum beta-lactamase bacteria in a neonatal intensive care unit. Pediatr Infect Dis J 2008;27:314-8.
60. Cotten CM, McDonald S, Stoll B, et al. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics 2006; 118:717-22.
61. Clark RH, Bloom BT, Spitzer AR, et al. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics 2006; 117:67-74.
62. Kuppala VS, Meinzen-Derr J, Morrow AL, et al. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr 2011;159: 720-5.
63. Cotten CM, Taylor S, Stoll B, et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009;123:58-66.
64. Alm B, Erdes L, Möllborg P, et al. Neonatal antibiotic treatment is a risk factor for early wheezing. Pediatrics 2008;121:697-702.
65. Lawrence SL, Roth V, Slinger R, et al. Cloxacillin versus vancomycin for presumed late-onset sepsis in the Neonatal Intensive Care Unit and the impact upon outcome of coagulase negative staphylococcal bacteremia: a retrospective cohort study. BMC Pediatr 2005;5:49.
66. Hsieh E, Smith PB, Jacqz-Aigrain E, et al. Neonatal fungal infections: when to treat? Early Hum Dev 2012;88(Suppl 2):S6-10.
67. Garcia-Prats JA, Cooper TR, Schneider VF, et al. Rapid detection of microorganisms in blood cultures of newborn infants utilizing an automated blood culture system. Pediatrics 2000;105(3 Pt 1):523-7.
68. Saini SS, Dutta S, Ray P, et al. Short course versus 7-day course of intravenous antibiotics for probable neonatal septicemia: a pilot, open-label, randomized controlled trial. Indian Pediatr 2011;48:19-24.
69. Cordero L, Ayers LW. Duration of empiric antibiotics for suspected early-onset sepsis in extremely low birth weight infants. Infect Control Hosp Epidemiol 2003;24:662-6.
70. Ehl S, Gering B, Bartmann P, et al. C-reactive protein is a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection. Pediatrics 1997;99: 216-21.
71. Al-Zwaini EJ. C-reactive protein: a useful marker for guiding duration of antibiotic therapy in suspected neonatal septicaemia? East Mediterr Health J 2009;15:269-75.
72. Stocker M, Fontana M, El Helou S, et al. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial. Neonatology 2010;97: 165-74.
73. Murphy K, Weiner J. Use of leukocyte counts in evaluation of early-onset neonatal sepsis. Pediatr Infect Dis J 2012;31:16-9.
74. Gathwala G, Sindwani A, Singh J, et al. Ten days vs. 14 days antibiotic therapy in culture-proven neonatal sepsis. J Trop Pediatr 2010;56:433-5.
75. Chowdhary G, Dutta S, Narang A. Randomized controlled trial of 7-Day vs. 14-Day antibiotics for neonatal sepsis. J Trop Pediatr 2006;52:427-32.
76. Hemels MAC, van den Hoogen A, Verboon-Maciolek MA, et al. Shortening the antibiotic course for the treatment of neonatal coagulase-negative staphylococcal sepsis: fine with three days? Neonatology 2012;101:101-5.
77. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39:1267-84.
78. Daoud AS, Batieha A, Al-Sheyyab M, et al. Lack of effectiveness of dexamethasone in neonatal bacterial meningitis. Eur J Pediatr 1999;158:230-3.
79. Mathur NB, Garg A, Mishra TK. Role of dexamethasone in neonatal meningitis: a randomized controlled trial. Indian J Pediatr 2013;80:102-7.
80. Thaver D, Ali SA, Zaidi AKM. Antimicrobial resistance among neonatal pathogens in developing countries. Pediatr Infect Dis J 2009;28(1 Suppl):S19-21.
81. Darmstadt GL, Batra M, Zaidi AKM. Oral antibiotics in the management of serious neonatal bacterial infections in developing country communities. Pediatr Infect Dis J 2009;28(1 Suppl):S31-6.
82. Bang AT, Reddy HM, Deshmukh MD, et al. Neonatal and infant mortality in the ten years (1993 to 2003) of the Gadchiroli field trial: effect of home-based neonatal care. J Perinatol 2005;25(Suppl 1):S92-107.
83. Darmstadt GL, Batra M, Zaidi AKM. Parenteral antibiotics for the treatment of serious neonatal bacterial infections in developing country settings. Pediatr Infect Dis J 2009;28(1 Suppl):S37-42.
84. Zaidi AKM, Tikmani SS, Warraich HJ, et al. Communitybased treatment of serious bacterial infections in newborns and young infants: a randomized controlled trial assessing three antibiotic regimens. Pediatr Infect Dis J 2012;31:667-72.
85. Rhee V, Mullany LC, Khatry SK, et al. Maternal and birth attendant hand washing and neonatal mortality in southern Nepal. Arch Pediatr Adolesc Med 2008;162:603-8.
86. Mullany LC, Darmstadt GL, Tielsch JM. Safety and impact of chlorhexidine antisepsis interventions for improving neonatal health in developing countries. Pediatr Infect Dis J 2006;25:665-75.
87. Vohr BR, Poindexter BB, Dusick AM, et al. Persistent beneficial effects of breast milk ingested in the neonatal intensive care unit on outcomes of extremely low birth weight infants at 30 months of age. Pediatrics 2007;120:e953-9.
88. Howie PW, Forsyth JS, Ogston SA, et al. Protective effect of breast feeding against infection. BMJ 1990;300:11-6.
89. Turin CG, Zea-Vera A, Pezo A, et al. Lactoferrin for prevention of neonatal sepsis. Biometals 2014;27:1007-16.
90. Manzoni P, Rinaldi M, Cattani S, et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA 2009;302:1421-8.
91. Akin IM, Atasay B, Dogu F, et al. Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells. Am J Perinatol 2014;31:1111-20.
92. Verani JR, McGee L, Schrag SJ, et al. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep 2010;59(RR-10):1-36.
93. Kaufman DA. Fluconazole prophylaxis: can we eliminate invasive Candida infections in the neonatal ICU? Curr Opin Pediatr 2008;20:332-40.
94. Benjamin DK, Hudak ML, Duara S, et al. Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial. JAMA 2014;311:1742-9.